Mechanisms and Disorders of Magnesium Metabolism

Seldin and Giebisch's The Kidney

Volumn , Issue , 2008, Pages 1747-1767

  Quamme, Gary A ^a,b,c   Schlingmann, Karl P ^a,b,c   Konrad, Martin ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44449135817     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088488-9.50064-4     Document Type: Chapter

References (169)

1. Ahmad A., Sutton R.A.L. Disorders of magnesium metabolism. The Kidney: Physiology and Pathophysiology 2000, 1732-1748. Raven Press, New York. D.W. Seldin, G. Giebisch (Eds.).
2. Aries P.M., Schubert M., Muller-Wieland D., et al. Subcutaneous magnesium pump in a patient with combined magnesium transport defect. Dtsch Med Wochenschr 2000, 125:970-972.
3. Arystarkhova E., Donnet C., Asinovski N.K., et al. Differential regulation of renal Na,KATPase by splice variants of the gamma subunit. J Biol Chem 2002, 277:10162-10172.
4. Arystarkhova E., Wetzel R.K., Sweadner K.J. Distribution and oligomeric association of splice forms of Na(+)-K(+)-ATPase regulatory gamma-subunit in rat kidney. Am J Physiol Ren Physiol 2002, 282:F393-F407.
5. Attie M.F., Gill J.R., Stock J.L., et al. Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. J Clin Invest 1983, 72:667-676.
6. Ba J., Friedman P.A. Calcium-sensing receptor regulation of renal magnesium mineral ion transport. Cell Calcium 2004, 35:229-237.
7. Bapty B.W., Dai L.-J., Ritchie G., et al. Extracellular of Mg2+ and Ca2+ sensing in mouse distal convoluted tubule cells. Kidney Int 1998, 53:583-592.
8. Barbagallo M., Dominguez L.J., Galioto A., et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003, 24:39-52.
9. Bartter F.C., Provoe P., Gill J.R., et al. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 1962, 33:811-828.
10. Benigno V., Cononica C.S., Bettinelli A., et al. Hypomagnesemia-hypercalciuria-nephrocalcinosis: a report of nine cases and a review. Nephrol Dial Transplant 2000, 15:605-610.
11. Bettinelli A., Rusconi R., Ciarmatori S., et al. Gitelman disease associated with growth hormone deficiency, disturbances in vasopressin secretion and empty sella: a new hereditary renal tubular-pituitary sy. Pediatr Res 1999, 46:232-238.
12. Bianchetti M.G ., Kanka C., Ridolfi-Luthy A., et al. Persisting renotubular sequella after cisplatin in children and adolescents. Am J Nephrol 1991, 11:127-130.
13. Birkenhager R., Otto E., Schurmann M.J., et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 2001, 29:310-314.
14. Blanchard A., Jeunemaitre X., Coudol P., et al. Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 2001, 59:2206-2215.
15. Blostein R., Pu H.X., Scanzano R., et al. Structure/function studies of the gamma subunit of the Na,K-ATPase. Ann N Y Acad Sci 2003, 986:420-427.
16. Boulikas T., Vougiouka M. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs. Oncol Rep 2004, 11:559-595.
17. Bruewer M., Hopkins A.M., Hobert M.E., et al. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin. Am J Physiol Cell Physiol 2004, 287:C327-C335.
18. Carrick S., Ghersi D., Wilcken N., et al. Platinum containing regimens for metastatic breast cancer. Cochrane Database Syst Rev 2004, 2. and 3 (CD003374).
19. Chubanov V., Waldegger S., Mederos y Schnitzler M., et al. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. Proc Natl Acad Sci U S A 2004, 101:2894-2899.
20. Coburn J.W., Massry S.G. Changes in serum and urinary calcium during phosphate depletion: studies on mechanism. J Clin Invest 1970, 49:1073-1087.
21. Cole D.E., Kooh S.W., Vieth R. Primary infantile hypomagnesaemia: outcome after 21 years and treatment with continuous nocturnal nasogastric magnesium infusion. Eur J Pediatr 2000, 159:38-43.
22. Cole D.E.C., Quamme G.A. Inherited disorders of renal magnesium handling. J Am Soc Nephrol 2000, 11:1937-1947.
23. Colegio O.R., Van Itallie C., Rahner C., et al. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol 2003, 284:C1346-C1354.
24. Crook M.A. Hypophosphatemia and hypokalemia in patients with hypomagnesemia. Br J Biomed Sci 1994, 51:24-27.
25. Cruz D.N., Shaer A.J., Bia M.J., et al. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 2001, 59:710-717.
26. Dai L.J., Bapty B., Ritchie G., et al. PGE2 stimulates Mg2+ uptake in mouse distal convoluted tubule cells. Am J Physiol 1998, 275:F833-F839.
27. Dai L.-J., Friedman P.A., Quamme G.A. Phosphate depletion diminishes Mg2+ uptake in mouse distal convoluted tubule cells. Kidney Int 1997, 51:1710-1718.
28. Dai L.-J., Friedman P.A., Quamme G.A. Cellular mechanisms of chlorothiazide and potassium depletion on Mg2+ uptake in mouse distal convoluted tubule cells. Kidney Int 1997, 51:1008-1017.
29. Dai L.J., Ritchie G., Kerstan D., et al. Magnesium transport in the renal distal convoluted tubule. Physiol Rev 2001, 81:51-84.
30. Desfleurs E., Wittner M., Pajaud S., et al. The Ca2+-sensing receptor in the rabbit cortical thick ascending limb (CTAL) is functionally not coupled to phospholipase C. Pflügers Arch 1999, 437:716-723.
31. Wittner M., Simeone S., et al. Calcium-sensing receptor: regulation of electrolyte transport in the thick ascending limb of Henle's loop. Kidney Blood Res 1998, 21:401-412.
32. 2+ reabsorption in the mouse cortical thick ascending limb of Henle's loop (CTAL) by low magnesium diet and metabolic alkalosis. The 2nd European Kidney Research Forum 1995, abstract P 015.
33. 2+ sensor in the thick ascending limb of the loop of Henle. Kidney Blood Press Res 1997, 20:190-193.
34. 2+ transport in cortical and medullary thick ascending limbs o. Pflügers Arch 1990, 417:161-167.
35. Dorovkov M.V., Ryazanov A.G. Phosphorylation of annexin I by TRPM7 channel-kinase. J Biol Chem 2004, 279:50643-50646.
36. Efrati E., Arsentiev-Rozenfeld J., Zelikovic I. The human paracellin-1 gene (hPCLN-1): renal epithelial cell-specific expression and regulation. Am J Physiol Renal Physiol 2005, 288:F272-F283.
37. Elalouf J.M., Roinel N., Rouffignac de C. Effects of dDAVP in rat juxtamedullary nephron: stimulation of medullary recycling. Am J Physiol 1985, 246:F291-F298.
38. Elisaf M., Kalaitzidis R., Siamopoulos K.C. Multiple electrolyte abnormalities after pamidronate administration. Nephron 1998, 79:337-339.
39. Elliott C., Newman N., Madan A. Gentamicin effects on urinary electrolyte excretion in healthy subjects. Clin Pharmacol Ther 2000, 67:16-21.
40. Embark H.M., Böhmer C., Palmada C., et al. Regulation of CLC-Ka/barttin by the ubiquitin ligase Nedd4-2 and the serum- and glucocorticoid-dependent kinases. Kidney Int 2004, 66:1918-1925.
41. English M.W., Skinner R., Pearson A.D., Price L., Wyllie R., Craft A.W. Dose-related nephrotoxicity of carboplatin in children. Br J Cancer 1999, 81:336-341.
42. + secretion. Nature 2001, 414:558-561.
43. Foglia P.E., Bettinelli A., Tosetto C., et al. Cardiac work up in primary renal hypokalaemiahypomagnesaemia (Gitelman syndrome). Nephrol Dial Transplant 2004, 19:1398-1402.
44. Frazao J.M., Martins P., Coburn J.W. The calcimimetic agents: perspectives for treatment. Kidney Int 2002, 80:149-154. (Suppl).
45. Garland H.O., Birdsey T.J., Davidge C.G., et al. Effects of gentamicin, neomycin and tobramycin on renal calcium and magnesium handling in two rat strains. Clin Exp Pharmacol Physiol 1994, 21:109-115.
46. Geven W.B., Monnens L.A., Willems H.L., et al. Renal magnesium wasting in two families with autosomal dominant inheritance. Kidney Int 1987, 31:1140-1144.
47. Geven W.B., Monnens L.A., Willems J.L., et al. Isolated autosomal recessive renal magnesium loss in two sisters. Clin Genet 1987, 32:398-402.
48. Giapros V.I., Cholevas V.I., Andronikou S.K. Acute effects of gentamicin on urinary electrolyte excretion in neonates. Pediatr Nephrol 1904, 19:322-325.
49. Gitelman H.J., Graham J.B., Welt L.G. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physician 1976, 79:221-223.
50. Goel M., Garcia R., Estacion M., et al. Regulation of Drosophila TRPL channels by immunophilin FKBP59. J Biol Chem 2001, 276:38762-38773.
51. Goren M.P. Cisplatin nephrotoxicity affects magnesium and calcium metabolism. Med Pediatr Oncol 2003, 41:186-189.
52. Guerrero-Romero F., Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002, 39:209-213.
53. Gwanyanya A., Amuzescu B., Zalharov S.I., et al. Magnesium inhibited, TRPM6/7-like channel in cardiac myocytes: permeation of divalent cations and pH-mediated regulation. J Physiol 2004, 559:761-776.
54. Hebert S.C. Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int 1996, 50:2129-2139.
55. Hirano T., Kobayashi N., Itoh T., et al. Null mutation of PCLN-1/claudin-16 results in bovine chronic interstitial nephritis. Genome Res 2000, 10:659-663.
56. Ho C., Conner D.A., Pollack M.R., et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 1995, 11:389-394.
57. Hofmann T., Schaefer M., Schultz G., et al. Subunit composition of mammalian transient receptor potential channels in living cells. Proc Natl Acad Sci U S A 2002, 99:7461-7466.
58. Hunter D.J., Lange M., Snieder H., et al. Genetic contribution to renal function and electrolyte balance: a twin study. Clin Sci (Lond) 2002, 103:259-265.
59. Husmann M.J., Fuchs P., Truttmann A.C., et al. Extracellular magnesium depletion in pediatric patients with insulin-dependent diabetes mellitus. Miner Electrolyte Metab 1997, 23:121-124.
60. Ikari A., Hirai N., Shiroma M., et al. Association of paracellin-1 with ZO-1 augments the reabsorption of divalent cations in renal epithelial cells. J Biol Chem 2004, 279:54826-54832.
61. Jeck N., Derst C., Wischmeyer E., et al. Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome. Kidney Int 2001, 59:1803-1811.
62. Jeck N., Konrad M., Peters M., et al. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res 2000, 48:754-758.
63. Jeck N., Reinalter S.C., Henne T., et al. Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics 2001, 108:E5.
64. Jeck N., Schlingmann K.P., Reinalter S.C., et al. Salt handling in the distal nephron: lessons learned from inherited human disorders. Am J Physiol Regul Integr Comp Physiol 2005, 288:R782-R795.
65. Jones D.H., Li T.Y., Arystarkhova E., et al. Na,K-ATPase from mice lacking the gamma subunit (FXYD2) exhibits altered Na+ affinity and decreased thermal stability. J Biol Chem 2005, 280:19003-19011.
66. 2+-uptake in mouse distal convoluted tubule cells. Can J Physiol Pharmacol 2000, 78:595-602.
67. Kantorovich V., Adams J.S., Gaines J.E., et al. Genetic heterogeneity in familial renal magnesium wasting. J Clin Endocrinol Metab 2002, 87:612-617.
68. Karolyi L., Ziegler A., Pollak M., et al. Gitelman's syndrome is genetically distinct from other forms of Bartter's syndrome. Pediatr Nephrol 1996, 10:551-554.
69. Keating M.J., Sethi M.R., Bodey G.P., et al. Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy. Cancer 1977, 39:1410-1414.
70. Kelepouris E., Agus Z.S. Hypomagnesemia: renal magnesium handling. Semin Nephrol 1998, 18:58-73.
71. Kerstan D., Quamme G.A. Physiology and pathophysiology of intestinal absorption of magnesium. Calcium in Internal Medicine 2002, 171-183. Springer-Verlag, Surry, UK. S.G. Massry, H. Morii, Y. Nishizawa (Eds.).
72. Khan L.A., Alam A.M., Ali L., Goswami A., et al. Serum and urinary magnesium in young diabetic subjects in Bangladesh. Am J Clin Nutr 1999, 69:70-73.
73. Kiuchi-Saishin Y., Gotoh S., Furuse M., et al. Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 2002, 13:875-886.
74. Kohler K., Louvard D., Zahraoui A. Rab13 regulates PKA signaling during tight junction assembly. J Cell Biol 2004, 165:175-180.
75. Konrad M., Vollmer M., Lemmink H.H., et al. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 2000, 11:1449-1459.
76. Konrad M., Weber S. Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 2003, 14:249-260.
77. Lajer H., Bundgaard H., Secher N.H., et al. Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin. Br J Cancer 2003, 89:1633-1637.
78. Lajer H., Daugaard G. Cisplatin and hypomagnesemia. Cancer Treat Rev 1999, 25:47-58.
79. Leliévre-Pegorier M., Merlet-Bénichou C., Roinel N., et al. Developmental pattern of water and electrolyte transport in the superficial nephron. Am J Physiol 1983, 244:F15-F21.
80. Lipschutz J.H., Li S., Arisco A., et al. Extracellular signal-regulated kinases 1/2 control claudin- 2 expression in Madin-Darby canine kidney strain I and Iicells. J Biol Chem 2005, 280:3780-3788.
81. 2+ handling in a mouse model for Gitelman's syndrome. J Am Soc Nephrol 2004, 15:2276-2288.
82. Lombeck I., Ritzl F., Schnippering H.G., et al. Primary hypomagnesemia. I. Absorption studies. Z Kinderheilkd 1975, 118:249-258.
83. Lote C.J., Thewles A., Wood J.A., et al. The hypomagnesaemic action of FK506: urinary excretion of magnesium and calcium and the role of parathyroid hormone. Clin Sci (Lond) 2000, 99:285-292.
84. Magil A.B., Mavichak V., Wong N.L., et al. Long-term morphological and biochemical observations in cisplatin-induced hypomagnesemia in rats. Nephron 1986, 43:223-230.
85. + transport in the cortical and medullary thick ascending limb of the rat nephron: influence of transepithelial voltage. Pflügers Arch 1993, 424:558-560.
86. Markmann M., Rothman R., Reichman B., et al. Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancer. J Cancer Res Clin Oncol 1991, 117:89-90.
87. Marx S.J., Attie M.F., Levine M.A., et al. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 1981, 60:235-242.
88. Massry S.G., Coburn J.W. The hormonal and non-hormonal control of renal excretion of calcium and magnesium. Nephron 1973, 10:66-112.
89. Matsumura Y., Uchida S., Kondo Y., et al. Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nat Genet 1999, 21:95-98.
90. Matzkin H., Lotan D., Boichis H. Primary hypomagnesemia with a probable double magnesium transport defect. Nephron 1989, 52:83-86.
91. Mavichak V., Coppin C.M.L., Wong N.M.L., et al. Renal magnesium wasting and hypocalciuria in chronic cis-platinum nephropathy in man. Clin Sci 1988, 75:203-207.
92. Mavichak V., Wong N.L., Quamme G.A., et al. Studies on the pathogenesis of cisplatininduced hypomagnesemia in rats. Kidney Int 1985, 28:914-921.
93. McLarnon S., Holden D., Ward D., et al. Aminoglycoside antibiotics induce pH-sensitive activation of the calcium-sensing receptor. Biochem Biophys Res Commun 2002, 297:71-77.
94. Meij I.C., Koenderink J.B., De Jong J.C., et al. Dominant isolated renal magnesium loss is caused by misrouting of the Na+,K+-ATPase gamma-subunit. Ann N Y Acad Sci 2003, 986:437-443.
95. Meij I.C., Koenderink J.B., van Bokhoven H., et al. Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. Nat Genet 2000, 26:265-266.
96. Meij I.C., Saar K., van den Heuvel L.P., et al. Hereditary isolated renal magnesium loss maps to chromosome 11q23. Am J Hum Genet 1999, 64:180-188.
97. Meij I.C., van den Heuvel L.P., Hemmes S., et al. Exclusion of mutations in FXYD2, CLDN16 and SLC12A3 in two families with primary renal Mg2+ loss. Nephrol Dial Transplant 2003, 18:512-516.
98. Mervaala E.M., Muller D.N., Park J.K., et al. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension 1999, 33:389-395.
99. Miura K., Nakatani T., Asai T., et al. Role of hypomagnesemia in chronic cyclosporine nephropathy. Transplantation 2002, 73:340-347.
100. Monteilh-Zoller M.K., Hermosura M.C., Nadler M.J., et al. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J Gen Physiol 2003, 121:49-60.
101. Montell C. Mg2+ homeostasis: the Mg2+nificent TRPM chanzymes. Curr Biol 2003, 13:R799-R801.
102. Motoyama H.I., Friedman P.A. Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs. Am J Physiol Renal Physiol 2002, 283:F399-F406.
103. Muller D., Kausalya P.J., Claverie-Martin F., et al. A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am J Hum Genet 2003, 73:1293-1301.
104. Nadler M.J., Hermosura M.C., Inabe K., et al. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature 2001, 411:590-595.
105. Nicholson J.C., Jones C.L., Powell H.R., et al. Familial hypomagnesaemia-hypercalciuria leading to end-stage renal failure. Pediatr Nephrol 1995, 9:74-76.
106. 2+ transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol 2004, 15:549-557.
107. 2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 2005, 115:1651-1658.
108. Ohba Y., Kitagawa H., Kitoh, et al. A deletion of the paracellin-1 gene is responsible for the renal tubular dysplasia in cattle. Genomics 2000, 68:229-236.
109. Paunier L., Radde I.C., Kooh S.W., et al. Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics 1968, 41:385-402.
110. Pearce S.H.S., Williamson C., Kifor O., et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 1996, 335:1115-1122.
111. Peters M., Ermert S., Jeck N., et al. Classification and rescue of ROMK mutations underlying hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int 2003, 64:923-932.
112. Peters M., Jeck N., Reinalter S., et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 2002, 112:183-190.
113. Peters N., Bettinelli A., Spicher I., et al. Renal tubular function in children and adolescents with Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome. Nephrol Dial Transplant 1995, 10:1313-1319.
114. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993, 75:1297-1303.
115. 2+-sensing receptor gene mutation. Nat Genet 1994, 8:303-307.
116. Praga M., Vara J., Gonzalez-Parra E., et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 1995, 47:1419-1425.
117. Quamme G.A. Control of magnesium transport in the thick ascending limb. Am J Physiol 1989, 256:F197-F210.
118. Quamme G.A. Laboratory evaluation of magnesium studies: renal function and free intracellular magnesium concentration. Clin Lab Med 1993, 13:209-223.
119. Quamme G.A. Renal magnesium handling: new insights in understanding old problems. Kidney Int 1997, 52:1180-1195.
120. Reilly R.F., Ellison D.H. Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol Rev 2000, 80:277-313.
121. Reyes J.L., Lamas M., Martin D., et al. The renal segmental distribution of claudins changes with development. Kidney Int 2002, 62:476-487.
122. 2+-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol 1996, 271:F951-F956.
123. 2+. Am J Physiol 2001, 280:F868-F878.
124. Rob P.M., Lebeau A., Nobiling R., et al. Magnesium metabolism: basic aspects and implications of cyclosporin toxicity in rats. Nephron 1996, 72:59-66.
125. Rodriguez M., Solanki D.L., Whang R. Refractory potassium repletion due to cisplatininduced magnesium depletion. Arch Intern Med 1989, 149:2592-2594.
126. Rouffignac de C. Multihormonal regulation of nephron epithelia: achieved through combinational mode?. Am J Physiol 1995, 269:R739-R748.
127. Rouffignac de C., Quamme G.A. Renal magnesium handling and its hormonal control. Physiol Rev 1994, 74:305-322.
128. Runnels L.W., Yue L., Clapham D.E. The TRPM7 channel is inactivated by PIP(2) hydrolysis. Nat Cell Biol 2002, 4:329-336.
129. Ryazanova L.V., Dorovkov M.V., Ansari A., et al. Characterization of the protein kinase activity of TRPM7/ChaK1, a protein kinase fused to the transient receptor potential ion channel. J Biol Chem 2004, 279:3708-3716.
130. Sabath E., Meade P., Berkman J., et al. Pathophysiology of functional mutations of the thiazidesensitive Na-Cl cotransporter in Gitelman disease. Am J Physiol 2004, 287:F195-F203.
131. Schlingmann K.P., Konrad M., Jeck N., et al. Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med 2004, 350:1314-1319.
132. Schlingmann K.P., Konrad M., Seyberth H.W. Genetics of hereditary disorders of magnesium homeostasis. Pediatr Nephrol 2004, 19:13-25.
133. Schlingmann K.P., Weber S., Peters M., et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002, 31:166-170.
134. 2+ homeostasis by TPRM7. Cell 2003, 114:20-191.
135. - cotransporter of the distal convoluted tubule. J Biol Chem 1998, 273:29150-29155.
136. Shah G.M., Kirschenbaum M.A. Renal magnesium wasting associated with therapeutic agents. Miner Electrolyte Metab 1991, 17:58-64.
137. Shalev H., Phillip M., Galil A., et al. Clinical presentation and outcome in primary familial hypomagnesaemia. Arch Dis Child 1998, 78:127-130.
138. Shareghi G.R., Agus Z.S. Magnesium transport in the cortical thick ascending limb of Henle's loop of the rabbit. J Clin Invest 1983, 69:759-769.
139. Simon D.B., Bindra R.S., Mansfield T.A., et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 1997, 17:171-178.
140. Simon D.B., Karet F.E., Hamdan J.M., et al. Bartter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996, 13:183-188.
141. 2+ resorption. Science 1999, 285:103-106.
142. - cotransporter. Nat Genet 1996, 12:24-30.
143. Singh A.B., Harris R.C. Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney c. J Biol Chem 2004, 279:3543-3552.
144. Swainson C.P., Colls B.M., Fitzharris B.M. Cis-platinum and distal renal tubule toxicity. N Z Med J 1985, 98:375-378.
145. Sweadner K.J., Arystarkhova E., Donnet C., et al. FXYD proteins as regulators of the Na,KATPase in the kidney. Ann N Y Acad Sci 2003, 986:382-387.
146. Takaya J., Higashino H., Kotera F., et al. Intracellular magnesium of platelets in children with diabetes and obesity. Metab Clin Exp 2003, 52:468-471.
147. Takezawa R., Schmitz C., Demeuse P., et al. Receptor-mediated regulation of the TRPM7 channel through its endogenous protein kinase domain. Proc Natl Acad Sci U S A 2004, 101:6009-6014.
148. Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med 1996, 156:1143-1148.
149. Vargas-Poussou R., Feldmann D., Vollmer M., et al. Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet 1998, 62:1332-1340.
150. Vargas-Poussou R., Huang C., Hulin P., et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 2002, 13:2259-2266.
151. Vetter T., Lohse M.J. Magnesium and the parathyroid. Curr Opin Nephrol Hypertens 2002, 11:403-410.
152. Voets T., Nilius B., Hoefs S., et al. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem 2004, 279:19-25.
153. Vollmer M., Jeck N., Lemmink H.H., et al. Antenatal Bartter syndrome with sensorineural deafness: refinement of the locus on chromosome 1p31. Nephrol Dial Transplant 2000, 15:970-974.
154. Vormann J. Magnesium: nutrition and metabolism. Mol Aspects Med 2003, 24:27-37.
155. Waldegger S., Jeck N., Barth P., et al. Barttin increases surface expression and changes current properties of ClC-K channels. Pflügers Arch 2002, 444:411-418.
156. Walder R.Y., Landau D., Meyer P., et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 2002, 31:171-174.
157. Walder R.Y., Shalev H., Brennan T.M., et al. Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: genetic linkage mapping and analysis of a balanced translocation breakpoint. Hum Mol Genet 1997, 6:1491-1497.
158. Ward D.T., McLarnon S.J., Riccardi D. Aminoglycosides increase intracellular calcium levels and ERK activity in proximal tubular OK cells expressing the extracellular calcium-sensing receptor. J Am Soc Nephrol 2002, 13:1481-1489.
159. Watanabe S., Fukumoto S., Chang H., et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 2002, 360:692-694.
160. Weber S., Hoffmann K., Jeck N., et al. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet 2000, 8:414-422.
161. Weber S., Schlingmann K.P., Peters M., et al. Primary gene structure and expression studies of rodent paracellin-1. J Am Soc Nephrol 2001, 12:2664-2672.
162. Weber S., Schneider L., Peters M., et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 2001, 12:1872-1881.
163. Weinberg J.M., Harding P.G., Humes H.D. Alterations in renal cortex cation homeostasis during mercuric chloride and gentamicin nephrotoxicity. Exp Mol Pathol 1983, 39:43-60.
164. Wilson F.H., Hariri A., Farhi A., et al. A cluster of metabolic defects caused by mutation in mitochondrial tRNA. Science 2004, 306:1190-1194.
165. Wittner M., Jounier S., Deschenes G., et al. Cellular adaptation of the mouse cortical thick ascending limb of Henle's loop (CTAL) to dietary magnesium restriction: enhanced transepithelial Mg2+ and Ca2+ transport. Pflügers Arch 2000, 439:765-771.
166. Wolf M.T., Dotsch J., Konrad M., et al. Follow-up of five patients with FHHNC due to mutations in the paracellin-1 gene. Pediatr Nephrol 2002, 17:602-608.
167. Wong N.L., Dirks J.H. Cyclosporin-induced hypomagnesaemia and renal magnesium wasting in rats. Clin Sci 1988, 75:509-514.
168. Wong N.L.M., Dirks J.H., Quamme G.A. Tubular maximum reabsorptive capacity for magnesium in the dog. Am J Physiol 1983, 244:F78-F83.
169. Wu M.-S., Chang C.-T., Huang C.-C., Yang C.-W. Cyclosporine reduces paracellin-1 expression and magnesium transport in thick ascending limb cells. J Am Soc Nephrol 2004, 15:266A.